Study to investigate prototype formulations of an antibiotic

• Research type

  Research Study

• Full title

  An open-label, partially randomised, partial crossover study to investigate the bioavailability of prototype oral formulations of eravacycline with edetate disodium dehydrate (EDTA) as an excipient relative to eravacycline reference product following a single oral dose in healthy subjects

• IRAS ID

  148178

• Contact name

  Stuart Mair

• Contact email

  stuart.mair@quotientclinical.com

• Sponsor organisation

  Tetraphase Pharmaceuticals Inc.

• Eudract number

  2014-000094-39

• ISRCTN Number

  to be registered

• REC name

  Wales REC 1

• REC reference

  14/WA/0025

• Date of REC Opinion

  14 Feb 2014

• REC opinion

  Further Information Favourable Opinion